Yuan et al. found that AACT expression was involved in immune suppression in glioma, and higher AACT expression was associated with lower CD4+ T cell levels, which indicated that AACT played a key role in the occurrence of glioma [50]. The gene discussed is CD4; the disease is central nervous system cancer.